[1]
2026. IMMUNOTHERAPY PREDICTING IMMUNOTHERAPY RESPONSE IN RECURRENT HEAD AND NECK CANCER USING MACHINE LEARNING AND TUMOR MICROENVIRONMENT SIGNATURES. Biomed Thought. 4, 1 (Jun. 2026), 151–176.